Tags

Type your tag names separated by a space and hit enter

[Dengue: an emerging infection in travelers].
Rev Prat. 2011 Jun; 61(6):755-9.RP

Abstract

Dengue is a common, mosquito borne, travel-related, viral infection in the tropical traveler caused by an arbovirus. This virus has 4 different serotypes and is responsible for approximately 50 to 100 million cases per year. Its incidence and geographic distribution are clearly increasing lately. Although occurring in tropical endemic areas, sporadic and autochthonous cases have been recently reported in temperate countries including France. The tropical influenza-like clinical presentation is not very specific except for rash. Diagnosis is facilitated by the existence of thrombocytopenia and the early detection of NS1 antigen using rapid test. Hemorragic forms with or without shock syndrome are rare in travelers and represent the severe manifestations especially in children. Their pathophysiology remains controversial. Management is essentially symptomatic. Aspirine should be avoided because of bleeding risk. Beyond individual (travel) or collective (endemic zone) vector control measures, the development of a quadrivalent vaccine seems about to succeed.

Authors+Show Affiliations

Service des maladies infectieuses et tropicales, CHU Avicenne, AP-HP, université Paris-13, 93009 Bobigny Cedex.No affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

21826915

Citation

Méchaï, Frédéric, and Olivier Bouchaud. "[Dengue: an Emerging Infection in Travelers]." La Revue Du Praticien, vol. 61, no. 6, 2011, pp. 755-9.
Méchaï F, Bouchaud O. [Dengue: an emerging infection in travelers]. Rev Prat. 2011;61(6):755-9.
Méchaï, F., & Bouchaud, O. (2011). [Dengue: an emerging infection in travelers]. La Revue Du Praticien, 61(6), 755-9.
Méchaï F, Bouchaud O. [Dengue: an Emerging Infection in Travelers]. Rev Prat. 2011;61(6):755-9. PubMed PMID: 21826915.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Dengue: an emerging infection in travelers]. AU - Méchaï,Frédéric, AU - Bouchaud,Olivier, PY - 2011/8/11/entrez PY - 2011/8/11/pubmed PY - 2011/9/2/medline SP - 755 EP - 9 JF - La Revue du praticien JO - Rev Prat VL - 61 IS - 6 N2 - Dengue is a common, mosquito borne, travel-related, viral infection in the tropical traveler caused by an arbovirus. This virus has 4 different serotypes and is responsible for approximately 50 to 100 million cases per year. Its incidence and geographic distribution are clearly increasing lately. Although occurring in tropical endemic areas, sporadic and autochthonous cases have been recently reported in temperate countries including France. The tropical influenza-like clinical presentation is not very specific except for rash. Diagnosis is facilitated by the existence of thrombocytopenia and the early detection of NS1 antigen using rapid test. Hemorragic forms with or without shock syndrome are rare in travelers and represent the severe manifestations especially in children. Their pathophysiology remains controversial. Management is essentially symptomatic. Aspirine should be avoided because of bleeding risk. Beyond individual (travel) or collective (endemic zone) vector control measures, the development of a quadrivalent vaccine seems about to succeed. SN - 0035-2640 UR - https://www.unboundmedicine.com/medline/citation/21826915/[Dengue:_an_emerging_infection_in_travelers]_ L2 - https://medlineplus.gov/dengue.html DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.